Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

HRAS G13R

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

HRAS G13R	Urothelial Cancer	HRAS G13R	Urothelial Cancer	tipifarnib Sensitive: C3 – Early Trials tipifarnib Sensitive : C3	tipifarnib Sensitive: C3 – Early Trials tipifarnib Sensitive : C3
HRAS G13R	Squamous Cell Carcinoma of Head and Neck	HRAS G13R	Squamous Cell Carcinoma of Head and Neck	tipifarnib Sensitive: D – Preclinical tipifarnib Sensitive : D	tipifarnib Sensitive: D – Preclinical tipifarnib Sensitive : D
HRAS G13R	Thyroid Gland Carcinoma	HRAS G13R	Thyroid Gland Carcinoma	FRAX597 Sensitive: D – Preclinical FRAX597 Sensitive : D	FRAX597 Sensitive: D – Preclinical FRAX597 Sensitive : D
HRAS G13R	Thyroid Gland Carcinoma	HRAS G13R	Thyroid Gland Carcinoma	trametinib + dasatinib Sensitive: D – Preclinical trametinib + dasatinib Sensitive : D	trametinib + dasatinib Sensitive: D – Preclinical trametinib + dasatinib Sensitive : D
HRAS G13R	Thyroid Gland Carcinoma	HRAS G13R	Thyroid Gland Carcinoma	trametinib Sensitive: D – Preclinical trametinib Sensitive : D	trametinib Sensitive: D – Preclinical trametinib Sensitive : D
HRAS G13R	Thyroid Gland Carcinoma	HRAS G13R	Thyroid Gland Carcinoma	dasatinib + SCH772984 Sensitive: D – Preclinical dasatinib + SCH772984 Sensitive : D	dasatinib + SCH772984 Sensitive: D – Preclinical dasatinib + SCH772984 Sensitive : D
HRAS G13R	Thyroid Gland Carcinoma	HRAS G13R	Thyroid Gland Carcinoma	dasatinib + selumetinib Sensitive: D – Preclinical dasatinib + selumetinib Sensitive : D	dasatinib + selumetinib Sensitive: D – Preclinical dasatinib + selumetinib Sensitive : D
HRAS G13R	Thyroid Gland Carcinoma	HRAS G13R	Thyroid Gland Carcinoma	selumetinib Sensitive: D – Preclinical selumetinib Sensitive : D	selumetinib Sensitive: D – Preclinical selumetinib Sensitive : D
HRAS G13R	Thyroid Gland Anaplastic Carcinoma	HRAS G13R	Thyroid Gland Anaplastic Carcinoma	CI-1040 Sensitive: D – Preclinical CI-1040 Sensitive : D	CI-1040 Sensitive: D – Preclinical CI-1040 Sensitive : D
HRAS G13R	Solid Tumor	HRAS G13R	Solid Tumor	trametinib Sensitive: D – Preclinical trametinib Sensitive : D	trametinib Sensitive: D – Preclinical trametinib Sensitive : D